Learn More
Medchemexpress LLC K858 racemic | 72926-24-0 | MFCD00181155 | 99.8% | 277.35 g·mol⁻1 | C13H15N3O2S | 10 MG

Supplier: Medchemexpress LLC HY1996610MG
K858 (racemic) is a small-molecule ATP-uncompetitive inhibitor of the mitotic kinesin Eg5 with an IC50 of 1.3 μM. Supplied as a solid powder, it is intended for cellular and biochemical research into mitosis, spindle dynamics, and antiproliferative mechanisms. Manufacturer guidance includes solubility and in vivo formulation protocols for experimental use.
- ATP-uncompetitive inhibitor of kinesin Eg5 (IC50 1.3 μM).
- High purity (99.8%).
- Solid powder form suitable for laboratory handling.
- Soluble in DMSO up to 100 mg/mL; ultrasonic assistance recommended.
- Includes in vivo formulation protocols for dosing studies.
- Available in small research quantities for preclinical experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.